The liver is an essential organ that takes care of clearing toxins in our bodies. Because it constantly deals with toxic substances, it is likely to be regularly injured. To overcome this, the liver has a unique capacity ...
May 31, 2022
0
215
In a recent study, an interdisciplinary research team from MedUni Vienna showed that functional magnetic resonance imaging (fMRI) can be used as a non-invasive method for predicting complications in chronic liver disease. ...
May 19, 2022
0
16
Those with a normal body mass index (BMI) with non-alcoholic fatty liver disease (NAFLD) are more likely to have cardiovascular disease than those who are overweight or living with obesity, according to research selected ...
May 13, 2022
0
13
New research to be presented at this year's European Congress of Clinical Microbiology & Infectious Diseases (ECCMID) in Lisbon, Portugal (23–26 April), suggests that people with elevated risk of developing a stroke or ...
Apr 14, 2022
0
8
Five grams of plastic particles on average enter the human gastrointestinal tract per person per week. This is roughly equivalent to the weight of a credit card. Whether ingested micro- and nanoplastics pose a health risk ...
Mar 24, 2022
0
4
February is American Heart Month, which makes this a good time to learn about pulmonary hypertension.
Feb 23, 2022
0
48
(HealthDay)—From 2002 to 2018, there was an increase in the prevalence of comorbid chronic conditions among cancer survivors, according to a study published in the Feb. 15 issue of Cancer.
Feb 3, 2022
0
12
(HealthDay)—In clinical guidelines issued by the American College of Gastroenterology and published online Jan. 10 in the American Journal of Gastroenterology, recommendations are presented for the management of acute-on-chronic ...
Jan 26, 2022
0
3
Food insecurity, the limited availability of nutritionally adequate food, is a growing public health concern in the United States. Over 35 million Americans experience food insecurity annually, according to the U.S. Department ...
Dec 16, 2021
0
3
Denmark's Novo Nordisk, the world's leading insulin maker, said Thursday it will buy US-based Dicerna Pharmaceuticals, a developer of RNA interference technology which targets genes that cause disease.
Nov 18, 2021
0
1
